Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

- Total revenues of $301,000 for quarter, and $818,000 for first six months of 2025, from sales and collaborative research agreement -

- 82 civilian hospitals now have VAC approval to purchase Symvess™ -

Read more at globenewswire.com